Although confirmation of these phenomena will have to await further investigation our present study clearly demonstrated the effectiveness of MKP‐1 in the pathogenesis of AD could be harnessed as a clinical treatment strategy for AD. The gene discussed is DUSP1; the disease is Alzheimer disease.